12/30/2024
3:01 PM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2024
3:05 PM | Evogene (Filer)
| Form 424B3 | |
11/27/2024
3:00 PM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2024
6:35 AM | Evogene (Filer)
| Form 424B3 | |
11/21/2024
6:30 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
5:52 AM | Evogene (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
09/29/2024
11:15 PM | Evogene (Filer)
| Form EFFECT | |
09/19/2024
3:15 PM | Evogene (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
09/17/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024
6:00 AM | Evogene (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/26/2024
8:30 AM | Evogene (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for EVGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. |
08/23/2024
7:50 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/22/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024
6:01 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/23/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
10:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
11:15 PM | Evogene (Filer)
| Form EFFECT | |
03/28/2024
3:45 PM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
8:16 AM | Evogene (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/20/2024
8:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2024
6:03 AM | Evogene (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
02/22/2024
6:00 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
6:01 AM | Evogene (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:30 PM | Evogene (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
